4,073 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Hardy Reed LLC

Hardy Reed LLC acquired a new position in shares of Doximity, Inc. (NASDAQ:DOCS) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 4,073 shares of the company’s stock, valued at approximately $217,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Global Retirement Partners LLC boosted its stake in Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after buying an additional 440 shares during the last quarter. UMB Bank n.a. boosted its stake in Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after buying an additional 235 shares during the last quarter. Farther Finance Advisors LLC boosted its stake in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after buying an additional 603 shares during the last quarter. Morse Asset Management Inc acquired a new stake in Doximity in the 3rd quarter worth about $46,000. Finally, Covestor Ltd boosted its stake in Doximity by 441.9% in the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company’s stock worth $73,000 after buying an additional 1,370 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Stock Performance

Doximity stock opened at $76.67 on Thursday. The stock’s 50 day moving average price is $59.34 and its 200 day moving average price is $48.55. The firm has a market capitalization of $14.31 billion, a PE ratio of 76.67, a price-to-earnings-growth ratio of 4.22 and a beta of 1.39. Doximity, Inc. has a one year low of $22.96 and a one year high of $85.21.

Insiders Place Their Bets

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares in the company, valued at $366,463.20. The trade was a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 37.40% of the stock is owned by company insiders.

Analysts Set New Price Targets

DOCS has been the topic of a number of research analyst reports. KeyCorp decreased their price target on Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 8th. Leerink Partnrs raised Doximity from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 7th. Mizuho lifted their price objective on Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Barclays lifted their price objective on Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research note on Monday, November 11th. Finally, The Goldman Sachs Group lifted their price objective on Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Eleven research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $64.22.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.